Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice.
about
Neuro-modulating effects of honokiol: a reviewEffect of a proprietary Magnolia and Phellodendron extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trialHonokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma modelHonokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosisHerbal Medicine for Anxiety, Depression and InsomniaHonokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cellsObovatol improves cognitive functions in animal models for Alzheimer's disease.Effect of Magnolia officinalis and Phellodendron amurense (Relora®) on cortisol and psychological mood state in moderately stressed subjects.Psychological interventions in the management of common skin conditions.Effects of magnolol and honokiol derived from traditional Chinese herbal remedies on gastrointestinal movementHonokiol promotes non-rapid eye movement sleep via the benzodiazepine site of the GABA(A) receptor in mice.The natural products magnolol and honokiol are positive allosteric modulators of both synaptic and extra-synaptic GABA(A) receptorsA Comparison between Extract Products of Magnolia officinalis on Memory Impairment and Amyloidogenesis in a Transgenic Mouse Model of Alzheimer's Disease.Hangekobokuto (Banxia-houpo-tang), a Kampo Medicine that Treats Functional Dyspepsia.Antineoplastic Effects of Honokiol on Melanoma.Adding Agnus Castus and Magnolia to Soy Isoflavones Relieves Sleep Disturbances Besides Postmenopausal Vasomotor Symptoms-Long Term Safety and EffectivenessPsychodermatological disorders: recognition and treatment.Plant natural products: from traditional compounds to new emerging drugs in cancer therapy.Is there a potential of misuse for Magnolia officinalis compounds/metabolites?Antimetastatic activity of honokiol in osteosarcoma.High Resolution UHPLC-MS Metabolomics and Sedative-Anxiolytic Effects of Latua pubiflora: A Mystic Plant used by Mapuche Amerindians.Magnolol Protects against MPTP/MPP(+)-Induced Toxicity via Inhibition of Oxidative Stress in In Vivo and In Vitro Models of Parkinson's Disease.Combined administration of the mixture of honokiol and magnolol and ginger oil evokes antidepressant-like synergism in rats.Ethanol extract of Magnolia officinalis prevents lipopolysaccharide-induced memory deficiency via its antineuroinflammatory and antiamyloidogenic effects.The anxiolytic effect of Sho-ju-sen, a Japanese herbal medicine, assessed by an elevated plus-maze test in mice.Confirmation of the anxiolytic-like effect of dihydrohonokiol following behavioural and biochemical assessments.Honokiol protects against carbon tetrachloride induced liver damage in the rat.Evaluation of anxiolytic activity of spray dried powders of two South Brazilian Passiflora species.H2-P, a honokiol derivative, exerts anti-angiogenesis effects via c-MYC signaling pathway in glioblastoma.Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.Inhibitory effect of ethanol extract of Magnolia officinalis on memory impairment and amyloidogenesis in a transgenic mouse model of Alzheimer's disease via regulating β-secretase activity.Does dihydrohonokiol, a potent anxiolytic compound, result in the development of benzodiazepine-like side effects?Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo.The anxiolytic effect of two oriental herbal drugs in Japan attributed to honokiol from magnolia bark.Application of the elevated plus-maze test in mice for evaluation of the content of honokiol in water extracts of magnolia.A Randomized Controlled Trial of Chinese Patent Medicine Xiao'er Biantong Granules in the Treatment of Functional Constipation in Children.
P2860
Q21129428-D33AF2A8-F897-4724-8E67-104DC55DF35AQ21245900-26840599-8859-442D-8B55-F2967FC867C5Q21560841-6B28A2DF-B68A-4CA9-AB77-4BD2C2D3CC54Q24669763-905C3DFC-D955-48BD-A2C6-BBD135008419Q26786225-F1ACB164-CD12-46DC-958D-DE93773839E1Q28290402-0D41CB44-098F-4018-9D36-5F822609F8FDQ34243963-E0669A4B-F54C-4F31-BC14-D464E0C77A09Q34655114-A328363E-6077-4ED0-B278-8D8F6C79A6EBQ35557463-3C53767A-6602-4D39-888F-578C1CD6A21BQ35615955-CAD8F918-2B62-446F-91A7-906697358FD8Q36254017-F48DDDCE-9BAF-4E48-A804-1A95AD5759B2Q36837698-ECD6D90F-1A00-43CF-9F82-02C44936D954Q37224596-1948BE99-B005-40B1-A882-1CCA0BAAD39FQ37292858-DB92DDB9-EEE0-4BF0-A505-FE7C6C087D05Q37615079-8000D677-256A-445F-808A-FC8FB0B17344Q37673193-FA4AF3FD-7DC1-497E-BFA9-7B5D11727E61Q37946496-1D5CBEE2-ED25-445C-9B62-B967A7E4CC72Q38265836-77D39081-5DA1-462A-9A06-BA88FF81FA1FQ38682461-91965986-6959-4FA0-A9FF-D2EFAD8C16FFQ39470506-D4D552F7-4F79-47F5-8F1A-F1C9303026FEQ41129220-E45B1983-2128-4377-820D-3E7D39327730Q42175955-4198F677-3217-4E59-BC42-88347D22C5B4Q43270486-BAF67A02-6C78-4780-A32B-50DA071DCF31Q43406863-0A86C5A5-B01D-4740-BC5A-7AC5DBF0636CQ43553641-7F7D2937-4BAC-44A5-AB19-E9B9C2392C81Q43615902-2D374D04-AAB7-493E-913E-7CCF3500CA05Q46827646-F55718AC-0D64-48BA-9DB8-4717E7869EE6Q47211398-E16B4F72-822D-480C-819B-48C995986E4CQ47697715-A61D131E-5620-41A5-B1CA-09E3DFA12A24Q48176419-DE0C249A-311F-46CA-AAE5-957D3FA1998CQ48606546-99FA5FC8-CD87-42E9-9DE5-F621C86B71C1Q48713116-76774D1D-3637-4D05-A11A-F0DCA4BCF5CAQ50057469-E15D6892-9C15-455B-A0CC-5EEEFCE9C58DQ52140494-BDD19611-E21D-4B40-9506-1BDFCDB2B616Q52173385-EF64B5AC-5264-4D00-AD0E-8737E25DA238Q55035786-4CA247BA-053C-4AB5-AA7F-56EEFD85AD1A
P2860
Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Behavioural pharmacological ch ...... evated plus-maze test in mice.
@en
Behavioural pharmacological ch ...... evated plus-maze test in mice.
@nl
type
label
Behavioural pharmacological ch ...... evated plus-maze test in mice.
@en
Behavioural pharmacological ch ...... evated plus-maze test in mice.
@nl
prefLabel
Behavioural pharmacological ch ...... evated plus-maze test in mice.
@en
Behavioural pharmacological ch ...... evated plus-maze test in mice.
@nl
P2093
P2860
P1476
Behavioural pharmacological ch ...... evated plus-maze test in mice.
@en
P2093
Kuribara H
Maruyama Y
Stavinoha WB
P2860
P304
P356
10.1111/J.2042-7158.1998.TB07146.X
P577
1998-07-01T00:00:00Z